# A Study in Migraine Prevention

> **NCT01184508** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 87 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** Placebo
- **DRUG:** LY2300559

## Key facts

- **NCT ID:** NCT01184508
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 87 (ACTUAL)
- **Why stopped:** Elevation of ALT and AST in some patients.
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184508, "A Study in Migraine Prevention". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01184508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*